bf/NASDAQ:NRSN_icon.jpeg

NASDAQ:NRSN

NeuroSense Therapeutics Ltd.

  • Stock

USD

Last Close

0.76

30/08 20:00

Market Cap

17.50M

Beta: -

Volume Today

1.35M

Avg: 65.36K

PE Ratio

−1.38

PFCF: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
asset turnover
cash per share
0.08
-
0.06
21.90%
1.77
2,674.16%
0.62
65.22%
0.20
68.12%
company equity multiplier
1.04
-
1.18
13.63%
1.27
7.37%
1.37
8.10%
-1.69
223.51%
days of inventory outstanding
days of payables outstanding
5.49K
-
days of sales outstanding
dividend yield
ebit per revenue
ebt per ebit
0.99
-
0.98
1.04%
0.72
26.14%
0.91
25.89%
0.85
6.87%
effective tax rate
-0.00
-
-0.00
91.36%
0.38
108,293.22%
0.09
75.79%
0.00
100.00%
enterprise value multiple
-34.57
-
-15.41
55.43%
-0.52
96.63%
-0.80
54.28%
-0.62
22.67%
fixed asset turnover
free cash flow per share
-0.05
-
-0.06
19.52%
-0.25
287.41%
-0.67
167.02%
-0.61
8.53%
gross profit margin
interest coverage
-247
-
-2.89K
1,069.23%
-903.47
-
-24.19
97.32%
inventory turnover
long term debt to capitalization
0.03
-
-0.04
258.99%
net income per ebt
1.00
-
1.00
0.37%
0.62
38.28%
0.91
46.96%
1
10.21%
net profit margin
operating cash flow per share
-0.05
-
-0.06
19.42%
-0.25
288.14%
-0.66
167.50%
-0.61
8.01%
operating profit margin
payables turnover
0.07
-
pretax profit margin
price fair value
48.16
-
67.09
39.30%
1.71
97.46%
2.50
46.47%
-5.71
328.74%
receivables turnover
return on assets
-1.28
-
-3.63
182.65%
-0.22
93.99%
-1.45
565.37%
-3.55
144.56%
return on capital employed
-1.35
-
-4.38
225.75%
-0.52
88.23%
-2.26
339.16%
47.00
2,175.48%
return on equity
-1.34
-
-4.29
221.18%
-0.28
93.55%
-1.99
619.29%
6.02
402.06%
total debt to capitalization
0.04
-
-0.08
326.53%

All numbers in USD (except ratios and percentages)